| 0 |
Antithrombin-directed RNA Interaction [EPC] |
1 |
0.0179 |
| 1 |
Small Interfering RNA [EPC] |
1 |
0.0063 |
| 2 |
Asparagine-specific Enzyme [EPC] |
51 |
0.0038 |
| 3 |
Mucocutaneous Epithelial Cell Growth Factor [EPC] |
1 |
0.0026 |
| 4 |
Benzodiazepine Antagonist [EPC] |
1 |
0.0011 |
| 5 |
Prostacycline [EPC] |
1 |
0.0011 |
| 6 |
Echinocandin Antifungal [EPC] |
8 |
0.0010 |
| 7 |
Glycolipid Disialoganglioside-directed Antibody [EPC] |
1 |
0.0009 |
| 8 |
Lipid Emulsion [EPC] |
1 |
0.0004 |
| 9 |
Vitamin K [EPC] |
3 |
0.0003 |
| 10 |
Oxytocic [EPC] |
1 |
0.0003 |
| 11 |
CD30-directed Immunoconjugate [EPC] |
3 |
0.0003 |
| 12 |
CD33-directed Immunoconjugate [EPC] |
1 |
0.0003 |
| 13 |
Survival of Motor Neuron 2 Splicing Modifier [EPC] |
1 |
0.0002 |
| 14 |
Substance P/Neurokinin-1 Receptor Antagonist [EPC] |
2 |
0.0002 |
| 15 |
Paramagnetic Contrast Agent [EPC] |
1 |
0.0002 |
| 16 |
Bile Acid [EPC] |
5 |
0.0002 |
| 17 |
Topoisomerase Inhibitor [EPC] |
16 |
0.0002 |
| 18 |
Nucleoside Metabolic Inhibitor [EPC] |
44 |
0.0002 |
| 19 |
Azole Antifungal [EPC] |
23 |
0.0001 |
| 20 |
Penem Antibacterial [EPC] |
5 |
0.0001 |
| 21 |
Parenteral Iron Replacement [EPC] |
2 |
0.0001 |
| 22 |
Alkylating Drug [EPC] |
35 |
0.0001 |
| 23 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
16 |
0.0001 |
| 24 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
16 |
0.0001 |
| 25 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
13 |
0.0001 |
| 26 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
3 |
0.0001 |
| 27 |
Folate Analog Metabolic Inhibitor [EPC] |
59 |
0.0001 |
| 28 |
Tetracycline-class Antibacterial [EPC] |
1 |
0.0001 |
| 29 |
Anticholinergic [EPC] |
2 |
0.0001 |
| 30 |
Quinolone Antimicrobial [EPC] |
1 |
0.0001 |
| 31 |
Oxazolidinone Antibacterial [EPC] |
3 |
0.0001 |
| 32 |
Serotonin-3 Receptor Antagonist [EPC] |
12 |
0.0001 |
| 33 |
Alkaloid [EPC] |
2 |
0.0001 |
| 34 |
Stimulant Laxative [EPC] |
1 |
0.0001 |
| 35 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
9 |
0.0001 |
| 36 |
General Anesthetic [EPC] |
3 |
0.0001 |
| 37 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
7 |
0.0001 |
| 38 |
Glycopeptide Antibacterial [EPC] |
4 |
0.0001 |
| 39 |
Prostaglandin E1 Analog [EPC] |
1 |
0.0001 |
| 40 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
8 |
0.0001 |
| 41 |
Xanthine Oxidase Inhibitor [EPC] |
9 |
0.0001 |
| 42 |
CD52-directed Cytolytic Antibody [EPC] |
1 |
0.0001 |
| 43 |
Cholinergic Muscarinic Antagonist [EPC] |
2 |
0.0001 |
| 44 |
Purine Antimetabolite [EPC] |
5 |
0.0001 |
| 45 |
Carbonic Anhydrase Inhibitor [EPC] |
1 |
0.0000 |
| 46 |
Nucleoside Analog Antiviral [EPC] |
4 |
0.0000 |
| 47 |
Fluoroquinolone Antibacterial [EPC] |
6 |
0.0000 |
| 48 |
Corticosteroid [EPC] |
59 |
0.0000 |
| 49 |
Aminoglycoside Antibacterial [EPC] |
2 |
0.0000 |
| 50 |
Prostaglandin Analog [EPC] |
4 |
0.0000 |
| 51 |
Estrogen [EPC] |
8 |
0.0000 |
| 52 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1 |
0.0000 |
| 53 |
Antimycobacterial [EPC] |
1 |
0.0000 |
| 54 |
Ester Local Anesthetic [EPC] |
2 |
0.0000 |
| 55 |
Janus Kinase Inhibitor [EPC] |
6 |
0.0000 |
| 56 |
Leukotriene Receptor Antagonist [EPC] |
1 |
0.0000 |
| 57 |
Osmotic Laxative [EPC] |
9 |
0.0000 |
| 58 |
Histamine-2 Receptor Antagonist [EPC] |
4 |
0.0000 |
| 59 |
Nitroimidazole Antimicrobial [EPC] |
2 |
0.0000 |
| 60 |
Non-Standardized Chemical Allergen [EPC] |
2 |
0.0000 |
| 61 |
Vitamin B12 [EPC] |
8 |
0.0000 |
| 62 |
Vitamin D [EPC] |
7 |
0.0000 |
| 63 |
Amide Local Anesthetic [EPC] |
2 |
0.0000 |
| 64 |
Protease Inhibitor [EPC] |
1 |
0.0000 |
| 65 |
Vitamin C [EPC] |
9 |
0.0000 |
| 66 |
Insulin [EPC] |
1 |
0.0000 |
| 67 |
Leukocyte Growth Factor [EPC] |
3 |
0.0000 |
| 68 |
Progestin [EPC] |
6 |
0.0000 |
| 69 |
Antiarrhythmic [EPC] |
2 |
0.0000 |
| 70 |
Macrolide Antimicrobial [EPC] |
1 |
0.0000 |
| 71 |
Central alpha-2 Adrenergic Agonist [EPC] |
1 |
0.0000 |
| 72 |
Loop Diuretic [EPC] |
8 |
0.0000 |
| 73 |
Cytochrome P450 3A Inhibitor [EPC] |
1 |
0.0000 |
| 74 |
BCL-2 Inhibitor [EPC] |
1 |
0.0000 |
| 75 |
CD20-directed Cytolytic Antibody [EPC] |
5 |
0.0000 |
| 76 |
Platelet Aggregation Inhibitor [EPC] |
9 |
0.0000 |
| 77 |
Opioid Agonist [EPC] |
4 |
0.0000 |
| 78 |
Platinum-based Drug [EPC] |
4 |
0.0000 |
| 79 |
Factor Xa Inhibitor [EPC] |
4 |
0.0000 |
| 80 |
Cardiac Glycoside [EPC] |
1 |
0.0000 |
| 81 |
Proton Pump Inhibitor [EPC] |
8 |
0.0000 |
| 82 |
Mood Stabilizer [EPC] |
3 |
0.0000 |
| 83 |
Anti-epileptic Agent [EPC] |
3 |
0.0000 |
| 84 |
Benzodiazepine [EPC] |
9 |
0.0000 |
| 85 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
16 |
0.0000 |
| 86 |
Dihydropyridine Calcium Channel Blocker [EPC] |
4 |
0.0000 |
| 87 |
Catecholamine [EPC] |
1 |
0.0000 |
| 88 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
1 |
0.0000 |
| 89 |
Aminosalicylate [EPC] |
1 |
0.0000 |
| 90 |
Thiazide Diuretic [EPC] |
2 |
0.0000 |
| 91 |
Antirheumatic Agent [EPC] |
1 |
0.0000 |
| 92 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1 |
0.0000 |
| 93 |
Insulin Analog [EPC] |
4 |
0.0000 |
| 94 |
Parathyroid Hormone Analog [EPC] |
1 |
0.0000 |
| 95 |
Tumor Necrosis Factor Blocker [EPC] |
8 |
0.0000 |
| 96 |
Interleukin-6 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 97 |
alpha-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 98 |
Atypical Antipsychotic [EPC] |
2 |
0.0000 |
| 99 |
beta-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 100 |
Angiotensin 2 Receptor Blocker [EPC] |
1 |
0.0000 |
| 101 |
HMG-CoA Reductase Inhibitor [EPC] |
1 |
0.0000 |